INTEGRITY project focused on scaffolded learning tools, mentoring, and nudging approaches for responsible conduct of research.
ELEVATE BV
Dutch SME providing specialist consultancy in pharmacovigilance monitoring, research integrity training, and co-creative pedagogical tool design for EU consortia.
Their core work
ELEVATE BV is a Dutch SME that provides specialized consultancy and support services across biomedical research and research ethics domains. Their work spans two distinct tracks: supporting pharmacovigilance and medication safety monitoring systems (particularly for pregnant and lactating populations), and developing training frameworks and pedagogical tools for responsible conduct of research. They contribute to large EU consortia as a specialist service provider rather than a primary research performer, delivering methodological expertise, co-creative design approaches, and scaffolded learning tools.
What they specialise in
ConcePTION project built an ecosystem for monitoring medication safety in pregnancy using biobanks and predictive models.
COSMIC project addressed disorders of adaptive immunity including rheumatoid arthritis and B-cell neoplasia through systems medicine.
INTEGRITY project applied co-creative design and scaffolded tools as pedagogical methods for empowering students.
How they've shifted over time
ELEVATE's early H2020 involvement (2015-2018) centered on biomedical research — polarity biology and systems medicine approaches to immune disorders like rheumatoid arthritis and B-cell neoplasia. From 2019 onward, they pivoted sharply toward two new directions: research ethics and integrity training (with pedagogical and behavioral tools), and pharmacovigilance data ecosystems for pregnancy safety. This shift suggests a move away from bench-science support toward applied consultancy in research governance and health data infrastructure.
ELEVATE appears to be consolidating around research governance, training design, and health data monitoring — areas where consultancy SMEs can deliver recurring value to large consortia.
How they like to work
ELEVATE never coordinates projects — they join as participants or third parties in larger consortia, consistently playing a support or specialist role. With 102 unique partners across 27 countries from just 4 projects, they operate within very large consortia rather than tight-knit teams. This pattern indicates they are brought in for specific deliverables or expertise packages rather than shaping overall project direction.
Despite only 4 projects, ELEVATE has touched 102 unique partners across 27 countries, reflecting participation in large pan-European consortia. Their network is broad but likely shallow — many one-time connections rather than deep recurring partnerships.
What sets them apart
ELEVATE occupies an unusual niche bridging biomedical research with research governance and training — few SMEs combine pharmacovigilance data expertise with pedagogical tool development for research integrity. Their value proposition for consortium builders is as a flexible Dutch SME that can fill specialist work packages in ethics, training design, or health data monitoring without the overhead of a university partner. Their third-party and participant roles suggest they are adaptable and low-friction to integrate into existing project structures.
Highlights from their portfolio
- ConcePTIONLarge-scale health ecosystem project (2019-2024) addressing a critical gap in medication safety for pregnant populations, involving biobank development and predictive modeling.
- INTEGRITYInnovative approach combining behavioral science (nudging, mentoring) with pedagogical design to address the systemic challenge of research misconduct across European institutions.